BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 941829)

  • 1. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.
    Pfeifer HJ; Greenblatt DJ; Koch-Weser J
    Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic lidocaine in suspected acute myocardial infarction.
    Goodman SL; Geiderman JM; Bernstein IJ
    JACEP; 1979 Jun; 8(6):221-4. PubMed ID: 449144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure.
    Wyman MG; Slaughter RL; Farolino DA; Gore S; Cannom DS; Goldreyer BN; Lalka D
    J Am Coll Cardiol; 1983 Oct; 2(4):764-9. PubMed ID: 6886235
    [No Abstract]   [Full Text] [Related]  

  • 7. Character of adverse effects of prophylactic lidocaine in the coronary care unit.
    Rademaker AW; Kellen J; Tam YK; Wyse DG
    Clin Pharmacol Ther; 1986 Jul; 40(1):71-80. PubMed ID: 3522031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine and procainamide toxicity during treatment of ventricular arrhythmias.
    Mattea J; Mattea E
    Am J Nurs; 1976 Sep; 76(9):1429-31. PubMed ID: 1048862
    [No Abstract]   [Full Text] [Related]  

  • 12. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine in the early phase of acute myocardial infarction: the controversy over prophylactic or selective use.
    Zehender M; Kasper W; Just H
    Clin Cardiol; 1990 Aug; 13(8):534-9. PubMed ID: 2204506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical toxicity of furosemide in hospitalized patients. A report from the Boston Collaborative Drug Surveillance Program.
    Greenblatt DJ; Duhme DW; Allen MD; Koch-Weser J
    Am Heart J; 1977 Jul; 94(1):6-13. PubMed ID: 868744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of early lidocaine levels in patients.
    Zito RA; Reid PR; Longstreth JA
    Am Heart J; 1977 Sep; 94(3):292-6. PubMed ID: 888762
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the general practitioner in the early management of acute myocardial infarction.
    Levenstein JH
    S Afr Med J; 1971 Oct; 45(40):1103-9. PubMed ID: 4399268
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.
    Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H
    Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lidocaine in the treatment of arrhythmia in acute myocardial infarct].
    Dunning AJ; Kettner H; Wesdorp JC
    Ned Tijdschr Geneeskd; 1969 Dec; 113(52):2319-24. PubMed ID: 5362041
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.
    Rydén L; Waldenström A; Ehn L; Holmberg S; Husaini M
    Br Heart J; 1973 Nov; 35(11):1124-31. PubMed ID: 4128310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.